Do Axial-Flow Heart Assist Pumps Provide QoL Improvements? Size Matters
This article was originally published in The Gray Sheet
Executive Summary
Small continuous-flow ventricular assist devices pose distinct "quality-of-life" advantages over pulsatile VADs, cardiac surgeon Stephen Westaby, MD, John Radcliffe Hospital in Oxford, UK, maintained Aug. 24
You may also be interested in...
Medicare LVAD “Category B” Coverage Critical To Non-Pulsatile Device Firms
CMS' imminent coverage decision on permanent implantation of left-ventricular assist devices may be limited to FDA-approved pulsatile designs
Medicare LVAD “Category B” Coverage Critical To Non-Pulsatile Device Firms
CMS' imminent coverage decision on permanent implantation of left-ventricular assist devices may be limited to FDA-approved pulsatile designs
Arrow Begins Non-Pulsatile VAD Trial, Targets Mid-Year LionHeart CE Mark
Arrow International will commence a 15-patient pilot trial of its centrifugal flow ventricular assist device in Europe by the end of February, the firm announced during its annual stockholders meeting Jan. 15